STOCK TITAN

AXS Rule 144 Notice — 2,200 Shares Sold via Morgan Stanley on NYSE

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Axis Capital Holders Limited (AXS): The filing reports a proposed sale of 2,200 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $211,200.00. The shares represent part of restricted stock that vested on 03/01/2024 (1,407 shares) and 03/01/2023 (793 shares). The filer previously sold the same 2,200 shares on 08/15/2025 in four transactions, producing combined gross proceeds of $211,463.78. The form includes the standard signer representation that no undisclosed material adverse information is known.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine insider sale disclosed under Rule 144; quantity is small relative to total shares outstanding.

The filing documents an insider disposing of 2,200 common shares via a broker on the NYSE, with the securities originating from restricted stock vesting in 2023 and 2024. The reported shares outstanding are 78,173,983, so the sale equals a de minimis percentage of outstanding stock. The notice lists both the proposed sale details and actual sales on 08/15/2025 with gross proceeds reported. For investors, this is a transparency event showing insider liquidity rather than a material corporate development.

TL;DR: Filing appears to comply with Rule 144 disclosure requirements and includes required signer attestations.

The form identifies the broker, number of shares, market value, share origin (restricted stock vesting), and prior sales in the past 3 months, matching Rule 144 presentation standards. The signer affirms absence of undisclosed material adverse information. No regulatory exceptions or incomplete mandatory fields are evident in the provided content, though some issuer identity fields in the extract are blank or not shown.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Form 144 filed for AXS report?

The filing reports a proposed sale of 2,200 common shares on the NYSE via Morgan Stanley Smith Barney with an aggregate market value listed as $211,200.00.

Where did the 2,200 shares come from?

The shares originated from restricted stock vesting: 1,407 shares vested on 03/01/2024 and 793 shares vested on 03/01/2023.

Were any shares sold in the past 3 months?

Yes. The filer sold 2,200 shares on 08/15/2025 across four transactions, with combined gross proceeds of $211,463.78.

How large is the sale relative to total shares outstanding?

The filing lists 78,173,983 shares outstanding; the 2,200-share sale is a de minimis portion of outstanding common shares.

Does the filer certify any material undisclosed information?

The signer represents they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.